TMO

Thermo Fisher Scientific

Health Care

Life Sciences Tools & Services

Waltham, Massachusetts

Balance Sheet 40 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
Assets - CashAndCashEquivalents	$4.0B	$8.1B	$8.5B	$4.5B	$10.3B
Assets - AccountsReceivable	$8.2B	$8.2B	$8.1B	$8.0B	$5.7B
Assets - Inventories	$5.0B	$5.1B	$5.6B	$5.1B	$4.0B
Assets - ContractAssetsCurrent	$1.4B	$1.4B	$1.3B	$968.0M	$731.0M
Assets - PrepaidExpensesAndOtherCurrentAssets	$2.0B	$1.8B	$1.6B	$1.6B	$1.1B
Assets - ShortTermInvestments	$1.6B	$3.0M	—	—	—
Assets - TotalCurrentAssets	$22.1B	$24.6B	$25.2B	$20.1B	$22.0B
Assets - Property,PlantAndEquipment	$9.3B	$9.4B	$9.3B	$8.3B	$5.9B
Assets - Goodwill	$45.9B	$44.0B	$41.2B	$41.9B	$26.0B
Assets - IntangibleAssets(net,ExcludingGoodwill)	$15.5B	$16.7B	$17.4B	$20.1B	$12.7B
Assets - OperatingLeaseAssets	$1.5B	$1.6B	$1.6B	$1.5B	$775.0M
Assets - EquityMethodInvestments	$357.0M	$489.0M	$369.0M	$576.0M	$32.0M
Assets - DeferredTaxAssets	$1.4B	$1.6B	$1.7B	$1.1B	$1.0B
Assets - LongTermInvestments	$41.0M	$12.0M	$55.0M	$22.0M	$28.0M
Assets - OtherNoncurrentAssets	$4.5B	$4.0B	$4.0B	$4.6B	$2.5B
Assets - TotalNoncurrentAssets	$10.8B	$11.0B	$10.9B	$9.9B	$6.7B
Assets - TotalAssets	$97.3B	$98.7B	$97.2B	$95.1B	$69.1B
Liabilities - AccountsPayable	$3.1B	$2.9B	$3.4B	$2.9B	$2.2B
Liabilities - AccruedLiabilities	$2.0B	$1.6B	$2.1B	$2.4B	$1.9B
Liabilities - ContractLiabilitiesCurrent(deferredRevenue)	$2.9B	$2.7B	$2.6B	$2.7B	$1.3B
Liabilities - ShortTermDebtAndCurrentPortionOfLongTermDebt	$2.2B	$3.6B	$5.6B	$2.5B	$2.6B
Liabilities - OperatingLeaseLiabilitiesCurrent	$261.0M	$263.0M	$272.0M	$266.0M	$184.0M
Liabilities - OtherCurrentLiabilities	$3.2B	$3.2B	$3.4B	$3.0B	$2.3B
Liabilities - TotalCurrentLiabilities	$13.3B	$14.0B	$17.0B	$13.4B	$10.3B
Liabilities - LongTermDebt	$31.1B	$34.7B	$34.3B	$34.7B	$19.1B
Liabilities - OperatingLeaseLiabilitiesNoncurrent	$1.2B	$1.2B	$1.3B	$1.2B	$626.0M
Liabilities - FinanceLeaseLiabilitiesNoncurrent	$202.0M	$190.0M	$210.0M	$200.0M	$7.0M
Liabilities - DeferredTaxLiabilitiesNoncurrent	$1.3B	$1.9B	$2.8B	$3.8B	$1.8B
Liabilities - OtherNoncurrentLiabilities	$4.0B	$4.6B	$4.2B	$4.5B	$3.3B
Equity - PreferredStock	$50.1K	$0	$0	$0	$50.1K
Equity - CommonStock	$444.0M	$442.0M	$441.0M	$439.0M	$437.0M
Equity - AdditionalPaidInCapital	$18.0B	$17.3B	$16.7B	$16.2B	$15.6B
Equity - RetainedEarnings(deficit)	$53.1B	$47.4B	$41.9B	$35.4B	$28.1B
Equity - TreasuryStock	$19.2B	$15.1B	$12.0B	$8.9B	$6.8B
Equity - AccumulatedOtherComprehensiveIncome(loss)	$-2.7B	$-3.2B	$-3.1B	$-2.3B	$-2.8B
Equity - NoncontrollingInterest(permanentEquity)	$-33.0M	$-11.0M	$54.0M	$62.0M	$10.0M
Equity - RedeemableNoncontrollingInterest	$120.0M	$118.0M	$116.0M	$122.0M	$0
Equity - TotalStockholdersEquity	$49.6B	$46.7B	$44.0B	$40.8B	$34.5B
Equity - TotalLiabilitiesAndStockholdersEquity	$97.3B	$98.7B	$97.2B	$95.1B	$69.1B

Income Statement 23 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
IncomeStatement - Revenues - NetRevenues/Sales	$42.9B	$42.9B	$44.9B	$39.2B	$32.2B
IncomeStatement - CostsAndExpenses - ResearchAndDevelopmentExpense	$1.4B	$1.3B	$1.5B	$1.4B	$1.2B
IncomeStatement - CostsAndExpenses - Selling,GeneralAndAdministrative	$8.6B	$8.4B	$9.0B	$8.0B	$6.9B
IncomeStatement - CostsAndExpenses - AmortizationOfIntangibleAssets(operating)	$2.0B	$2.3B	$2.4B	$1.8B	$1.7B
IncomeStatement - CostsAndExpenses - Depreciation(operating)	$1.2B	$1.1B	$986.0M	$831.0M	$658.0M
IncomeStatement - CostsAndExpenses - RestructuringCharges	$97.0M	$194.0M	$68.0M	$37.0M	$51.0M
IncomeStatement - OtherIncomeExpense - OperatingIncome(loss)	$7.3B	$6.9B	$8.4B	$10.0B	$7.8B
IncomeStatement - OtherIncomeExpense - InterestExpense	$1.4B	$1.4B	$726.0M	$536.0M	$553.0M
IncomeStatement - OtherIncomeExpense - InterestIncome	$1.1B	$879.0M	$272.0M	$43.0M	$65.0M
IncomeStatement - OtherIncomeExpense - Gain(loss)OnInvestments/equityMethod	$-42.0M	$-59.0M	$-172.0M	$-4.0M	$-3.0M
IncomeStatement - OtherIncomeExpense - OtherNonoperatingIncome(expense)	$12.0M	$-65.0M	$-104.0M	$-694.0M	$-76.0M
IncomeStatement - OtherIncomeExpense - Income(loss)FromContinuingOperationsBeforeIncomeTaxes	$7.0B	$6.3B	$7.8B	$8.8B	$7.2B
IncomeStatement - IncomeTax - IncomeTaxExpense(benefit)	$657.0M	$284.0M	$703.0M	$1.1B	$850.0M
IncomeStatement - IncomeTax - EffectiveTaxRate(continuingOperations)	$66.0M	$39.0M	$69.0M	$-5.0M	$42.0M
IncomeStatement - NetIncomeAndEps - NetIncome(loss)	$6.3B	$6.0B	$7.0B	$7.7B	$6.4B
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToNoncontrollingInterest	$3.0M	$-40.0M	$10.0M	$3.0M	$2.0M
IncomeStatement - NetIncomeAndEps - NetIncome(loss)AttributableToCompany	$6.3B	$6.0B	$7.0B	$7.7B	$6.4B
IncomeStatement - NetIncomeAndEps - BasicEarningsPerShare	$17	$16	$18	$20	$16
IncomeStatement - NetIncomeAndEps - DilutedEarningsPerShare	$17	$15	$18	$19	$16
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingBasic	$382.0M	$386.0M	$392.0M	$394.0M	$396.0M
IncomeStatement - NetIncomeAndEps - WeightedAverageSharesOutstandingDiluted	$383.0M	$388.0M	$394.0M	$397.0M	$399.0M
IncomeStatement - NetIncomeAndEps - ComprehensiveIncome(loss)	$6.9B	$5.9B	$6.2B	$8.2B	$6.2B

Cash Flow Statement 23 Accounts • 5 Years

Account	2024	2023	2022	2021	2020
end	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31
CashFlow - OperatingActivities - DepreciationAndAmortization	$1.2B	$1.1B	$986.0M	$831.0M	$658.0M
CashFlow - OperatingActivities - ShareBasedCompensation	$301.0M	$278.0M	$307.0M	$230.0M	$196.0M
CashFlow - OperatingActivities - DeferredIncomeTaxes	$-1.2B	$-1.3B	$-997.0M	$-645.0M	$-269.0M
CashFlow - OperatingActivities - ChangesInOperatingAssetsAndLiabilities	$186.0M	$802.0M	$47.0M	$945.0M	$-1.5B
CashFlow - OperatingActivities - NetCashFromOperatingActivities	$8.7B	$8.4B	$9.2B	$9.3B	$8.3B
CashFlow - InvestingActivities - CapitalExpenditures(pp&e&Software)	$1.4B	$1.5B	$2.2B	$2.5B	$1.5B
CashFlow - InvestingActivities - AcquisitionsOfBusinesses,NetOfCash	$3.1B	$3.7B	$39.0M	$19.4B	$38.0M
CashFlow - InvestingActivities - Purchases/salesOfInvestments	$3.4B	$208.0M	$52.0M	—	—
CashFlow - InvestingActivities - ProceedsFromSaleOfProperty,PlantAndEquipment	$57.0M	$87.0M	$24.0M	$20.0M	$8.0M
CashFlow - InvestingActivities - OtherInvestingActivities	$-8.0M	$-33.0M	$-20.0M	$42.0M	$6.0M
CashFlow - InvestingActivities - NetCashFromInvestingActivities	$-5.8B	$-5.1B	$-2.2B	$-21.9B	$-1.5B
CashFlow - FinancingActivities - ProceedsFromIssuanceOfDebt	$1.2B	$5.9B	$3.2B	$18.1B	$3.5B
CashFlow - FinancingActivities - RepaymentsOfDebt	$3.6B	$5.8B	$375.0M	$11.7B	$710.0M
CashFlow - FinancingActivities - PaymentsForRepurchaseOfCommonStock	$4.0B	$3.0B	$3.0B	$2.0B	$1.5B
CashFlow - FinancingActivities - PaymentOfDividends	$583.0M	$523.0M	$455.0M	$395.0M	$337.0M
CashFlow - FinancingActivities - OtherFinancingActivities	$195.0M	$56.0M	$-9.0M	$65.0M	$46.0M
CashFlow - FinancingActivities - NetCashFromFinancingActivities	$-6.8B	$-3.6B	$-2.8B	$6.6B	$959.0M
CashFlow - CashReconciliationAndSupplemental - EffectOfExchangeRateChangesOnCash	$-91.0M	$-82.0M	$-139.0M	$194.0M	$176.0M
CashFlow - CashReconciliationAndSupplemental - NetChangeInCash	$-4.1B	$-440.0M	$4.0B	$-5.8B	$7.9B
CashFlow - CashReconciliationAndSupplemental - IncomeTaxesPaid	$1.8B	$1.5B	$1.2B	$2.2B	$1.3B
CashFlow - CashReconciliationAndSupplemental - InterestPaid	$1.6B	$1.4B	$667.0M	$555.0M	$471.0M
CashFlow - CashReconciliationAndSupplemental - RightOfUseAssetsObtainedForLeases(nonCash)	$262.0M	$234.0M	$430.0M	$293.0M	$202.0M

Thermo Fisher Scientific

Balance Sheet 40 Accounts • 5 Years

Income Statement 23 Accounts • 5 Years

Cash Flow Statement 23 Accounts • 5 Years

Stock Market Data (1 Year) Live Yahoo Finance Data

Recent Price History